Live feed
Filing
SC 13D
SC 13D0001387131-19-005254·NeuBase Therapeutics, Inc.
Schedule 13D ownership disclosure
NeuBase Therapeutics, Inc.
Security class unavailable · CUSIP: 64132K102
Event date: 2019-07-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,859,569
- Percent of class
- 34.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-19-005254
- Form type
- SC 13D
- Filer
- NeuBase Therapeutics, Inc.
- CIK
- CIK 1173281
- Filed
- Jul 22, 2019
- Reporting period
- Jul 12, 2019
- Description
- Schedule 13D beneficial ownership